Modus Therapeutics Holding AB
Edit

Modus Therapeutics Holding AB

http://www.modustx.com/
Tags:CareCauseCollegeDataDrugGrowthHumanITMarketMedTech
Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
Location: Sweden, Stockholm
Member count: 1-10
Total raised: $23.133091M
Founded date: 2011

Investors 2

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
15.07.2021-$3.810126M-marketscre...
13.07.2018-$15.756512...-finsmes.co...
21.02.2017-$3.566453M-finsmes.co...

Mentions in press and media 39

DateTitleDescriptionCategoryAuthorSource
22.11.2022Modus Ther...Modus Therapeutics publishes i...--news.cisio...
01.09.2022Modus Ther...Modus Therapeutics announces f...--news.cisio...
23.08.2022Modus Ther...Modus Therapeutics publishes i...--news.cisio...
10.06.2022Modus Ther...Modus Therapeutics presents at...--news.cisio...
25.05.2022Modus Ther...Modus Therapeutics Updates on ...--news.cisio...
16.05.2022Modus Ther...Modus Therapeutics publishes i...--news.cisio...
12.05.2022Modus Ther...Modus Therapeutics secures acc...--news.cisio...
11.05.2022Annual Gen...Annual General Meeting in Modu...--news.cisio...
22.04.2022New public...New publication date for Modus...--news.cisio...
19.04.2022Modus Ther...Modus Therapeutics Holding AB ...--news.cisio...
Show more